Neogen Balance Sheet Health
Financial Health criteria checks 2/6
Neogen has a total shareholder equity of $3.1B and total debt of $888.8M, which brings its debt-to-equity ratio to 28.3%. Its total assets and total liabilities are $4.6B and $1.4B respectively. Neogen's EBIT is $130.5M making its interest coverage ratio 2. It has cash and short-term investments of $170.5M.
Key information
28.3%
Debt to equity ratio
US$888.82m
Debt
| Interest coverage ratio | 2x |
| Cash | US$170.54m |
| Equity | US$3.15b |
| Total liabilities | US$1.44b |
| Total assets | US$4.58b |
Recent financial health updates
Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt
Mar 29
Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly
Dec 06Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Jul 12Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Mar 25Recent updates
Battered By M&A Integration Issues, Neogen Has To Rebuild Investor Trust
Apr 15Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
Apr 12Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt
Mar 29Neogen: All About Execution From Here On
Mar 26Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are
Jan 17Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Jan 12Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected
Jan 09Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly
Dec 06Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Jul 12Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?
Jun 20Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Mar 25Neogen introduces ready-to-use disinfectant Companion RTU for veterinary use
Oct 10Neogen GAAP EPS of $0.05, revenue of $132.35M
Sep 27Neogen drops 9% as merger with 3M’s food safety business closes
Sep 01Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher
Aug 21Neogen: Cut In Half, Still Some Questions
Aug 12There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings
Aug 04Neogen: Thesis Unchanged After Q4 And Full-Year Earnings
Aug 01Neogen FQ4 2022 Earnings Preview
Jul 25Zoetis, IDEXX named as buys in animal health space by Piper Sandler
Jul 13Neogen announces pricing of $350M senior notes offering
Jul 07Neogen: Safety Food Giant In The Making
Dec 15Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends
Dec 12Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends
Sep 12Robust Valuation Leaves Neogen Little Room For Error After Mixed Results
Jul 27There Are Reasons To Feel Uneasy About Neogen's (NASDAQ:NEOG) Returns On Capital
Jun 10Financial Position Analysis
Short Term Liabilities: NEOG's short term assets ($602.5M) exceed its short term liabilities ($157.8M).
Long Term Liabilities: NEOG's short term assets ($602.5M) do not cover its long term liabilities ($1.3B).
Debt to Equity History and Analysis
Debt Level: NEOG's net debt to equity ratio (22.8%) is considered satisfactory.
Reducing Debt: NEOG's debt to equity ratio has increased from 0% to 28.3% over the past 5 years.
Debt Coverage: NEOG's debt is not well covered by operating cash flow (11.2%).
Interest Coverage: NEOG's interest payments on its debt are not well covered by EBIT (2x coverage).